Latest Apollo Projects
a collaboration with Prof John Trowsdale, University of Cambridge
By Richard Butt
Prof Trowsdale has demonstrated Siglec-15 to be upregulated on a subset of tumour cells. A therapeutic mAb is hypothesized to be a useful therapeutic mechanism to either modify the tumour microenvironment to permit immune cell clearance of the tumour, or as a target for an ADC to directly kill the tumour cells. Based on this research Apollo and the Prof Trowsdale are developing novel mAb therapeutics.
< PREV ITEM | > NEXT ITEM a collaboration with Dr Yorgo Modis, University of Cambridge